486 related articles for article (PubMed ID: 17469102)
21. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
[TBL] [Abstract][Full Text] [Related]
22. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis.
Poór G; Nagy ZB; Schmidt Z; Brózik M; Merétey K; Gergely P
Ann N Y Acad Sci; 2007 Sep; 1110():23-32. PubMed ID: 17911417
[TBL] [Abstract][Full Text] [Related]
23. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination.
Klareskog L; Stolt P; Lundberg K; Källberg H; Bengtsson C; Grunewald J; Rönnelid J; Harris HE; Ulfgren AK; Rantapää-Dahlqvist S; Eklund A; Padyukov L; Alfredsson L
Arthritis Rheum; 2006 Jan; 54(1):38-46. PubMed ID: 16385494
[TBL] [Abstract][Full Text] [Related]
24. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus.
Chan MT; Owen P; Dunphy J; Cox B; Carmichael C; Korendowych E; McHugh NJ
J Rheumatol; 2008 Jan; 35(1):77-83. PubMed ID: 18085741
[TBL] [Abstract][Full Text] [Related]
25. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles.
Linn-Rasker SP; van der Helm-van Mil AH; van Gaalen FA; Kloppenburg M; de Vries RR; le Cessie S; Breedveld FC; Toes RE; Huizinga TW
Ann Rheum Dis; 2006 Mar; 65(3):366-71. PubMed ID: 16014670
[TBL] [Abstract][Full Text] [Related]
26. A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis.
Berglin E; Padyukov L; Sundin U; Hallmans G; Stenlund H; Van Venrooij WJ; Klareskog L; Dahlqvist SR
Arthritis Res Ther; 2004; 6(4):R303-8. PubMed ID: 15225365
[TBL] [Abstract][Full Text] [Related]
27. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
Kapitány A; Szabó Z; Lakos G; Aleksza M; Végvári A; Soós L; Karányi Z; Sipka S; Szegedi G; Szekanecz Z
Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568
[TBL] [Abstract][Full Text] [Related]
28. Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.
Okada Y; Yamada R; Suzuki A; Kochi Y; Shimane K; Myouzen K; Kubo M; Nakamura Y; Yamamoto K
Arthritis Rheum; 2009 Dec; 60(12):3582-90. PubMed ID: 19950296
[TBL] [Abstract][Full Text] [Related]
29. Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis.
López-Longo FJ; Oliver-Miñarro D; de la Torre I; González-Díaz de Rábago E; Sánchez-Ramón S; Rodríguez-Mahou M; Paravisini A; Monteagudo I; González CM; García-Castro M; Casas MD; Carreño L
Arthritis Rheum; 2009 Apr; 61(4):419-24. PubMed ID: 19333979
[TBL] [Abstract][Full Text] [Related]
30. Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis.
Hoppe B; Häupl T; Egerer K; Gruber R; Kiesewetter H; Salama A; Burmester GR; Dörner T
Ann Rheum Dis; 2009 Jun; 68(6):898-903. PubMed ID: 18633125
[TBL] [Abstract][Full Text] [Related]
31. Gene-environmental interaction between smoking and shared epitope on the development of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: a meta-analysis.
Lee YH; Bae SC; Song GG
Int J Rheum Dis; 2014 Jun; 17(5):528-35. PubMed ID: 24618101
[TBL] [Abstract][Full Text] [Related]
32. Auto-antibodies, HLA and PTPN22: susceptibility markers for rheumatoid arthritis.
Orozco G; Pascual-Salcedo D; López-Nevot MA; Cobo T; Cabezón A; Martín-Mola E; Balsa A; Martín J
Rheumatology (Oxford); 2008 Feb; 47(2):138-41. PubMed ID: 18156150
[TBL] [Abstract][Full Text] [Related]
33. Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study.
Hoppe B; Häupl T; Gruber R; Kiesewetter H; Burmester GR; Salama A; Dörner T
Arthritis Res Ther; 2006; 8(2):R34. PubMed ID: 16469113
[TBL] [Abstract][Full Text] [Related]
34. Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles.
Verpoort KN; Cheung K; Ioan-Facsinay A; van der Helm-van Mil AH; de Vries-Bouwstra JK; Allaart CF; Drijfhout JW; de Vries RR; Breedveld FC; Huizinga TW; Pruijn GJ; Toes RE
Arthritis Rheum; 2007 Dec; 56(12):3949-52. PubMed ID: 18050209
[TBL] [Abstract][Full Text] [Related]
35. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
[TBL] [Abstract][Full Text] [Related]
36. Contribution of anti-CCP antibodies, proximal interphalangeal joint involvement, HLA-DRB1 shared epitope, and PADI4 as risk factors for the development of rheumatoid arthritis in palindromic rheumatism.
Tamai M; Kawakami A; Iwamoto N; Arima K; Aoyagi K; Eguchi K
Scand J Rheumatol; 2010 Aug; 39(4):287-91. PubMed ID: 20476860
[TBL] [Abstract][Full Text] [Related]
37. Redefining the HLA and RA association: to be or not to be anti-CCP positive.
de Vries RR; Huizinga TW; Toes RE
J Autoimmun; 2005; 25 Suppl():21-5. PubMed ID: 16257178
[TBL] [Abstract][Full Text] [Related]
38. Hormonal replacement therapy may reduce the risk for RA in women with early arthritis who carry HLA-DRB1 *01 and/or *04 alleles by protecting against the production of anti-CCP: results from the ESPOIR cohort.
Salliot C; Bombardier C; Saraux A; Combe B; Dougados M
Ann Rheum Dis; 2010 Sep; 69(9):1683-6. PubMed ID: 19740903
[TBL] [Abstract][Full Text] [Related]
39. New classification of the shared epitope in rheumatoid arthritis: impact on the production of various anti-citrullinated protein antibodies.
Gyetvai A; Szekanecz Z; Soós L; Szabó Z; Fekete A; Kapitány A; Teodorescu M; Sipka S; Szegedi G; Lakos G
Rheumatology (Oxford); 2010 Jan; 49(1):25-33. PubMed ID: 19920092
[TBL] [Abstract][Full Text] [Related]
40. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
